Salem Investment Counselors’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
29,200
+14,900
+104% +$85.1K 0.01% 407
2026
Q1
$67.1K Hold
14,300
﹤0.01% 543
2025
Q4
$110K Buy
14,300
+2,200
+18% +$17.2K ﹤0.01% 387
2025
Q3
$86.2K Buy
+12,100
New +$87.8K ﹤0.01% 493

Other funds holding DERM

Salem Investment Counselors's DERM Position: Q2 2026 in Review

Salem Investment Counselors increased its Journey Medical (DERM) stake by 104% in Q2 2026, buying an estimated $85.1K and bringing the position to 29,200 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #407.

Salem Investment Counselors first reported a position in DERM in Q3 2025 and has held it in 4 quarters since. 7 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Salem Investment Counselors held 29,200 shares of Journey Medical worth $207K as of Q2 2026.
  • Salem Investment Counselors bought 14,900 Journey Medical shares in Q2 2026, an estimated $85.1K.
  • Journey Medical made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #407 holding.
  • Salem Investment Counselors first reported a position in Journey Medical in Q3 2025 and has held it in 4 quarters since.
  • 7 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.